Resources

Type of publications
Regions
Diseases
5052 results found
2025 ∙ Lee, H. Cho, J. Y. Vietri, J. Dawson, E. Chaiyakunapruk, N.
The incremental net monetary benefit of higher-valent pneumococcal conjugate vaccines for adults: a systematic review and meta-analysis of economic evaluations
Adults Older adults Pneumococcal disease Economic aspects Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ de Almeida Santos, G. de Albuquerque Luna, E. J.
The influence of the COVID-19 pandemic on measles vaccination coverage
Newborn Children Adolescents Measles Coverage Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Wu, W. Liu, J. Guo, S. Zhao, H. Yang, X.
The protective efficacy of inactivated vaccine against hemorrhagic fever with renal syndrome A meta-analysis
All age groups Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Robitaille, J. Esser, K. King, C. Leask, J. Wiley, K. Vigod, S. Rodin, G. Bolotin, S. Shapiro, G. K.
The Relationship Between Postpartum Depression and Timely Child Vaccination: A Systematic Review
Newborn Children Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Ali Sheikhi, R. Heidari, M. Doosti, P.
The role of religious leaders in the acceptance of COVID-19 vaccinations: a systematic review
All age groups COVID-19 Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Shuai, T. Dong, M. Wu, P. Zhang, L. Feng, Z. Li, W. Liu, J.
The safety and efficacy of non-typeable Haemophilus influenzae and Moraxella catarrhalis vaccine in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials
All age groups Haemophilus influenzae type B Moraxella catarrhalis Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
Moderate
2025 ∙ Valdecantos, R. L. Sorrentino, M. Mercogliano, M. Giordano, V. Trama, U. Triassi, M. Palladino, R.
The structural and organizational aspects of human papillomavirus vaccine affecting immunization coverage in Europe: a systematic review
Europe Adolescents Adults Older adults Human papillomavirus (HPV) Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Jacobsen, I. M. Carlander, A. L. F. Aakilde, M. von Buchwald, C.
Trends in the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis following implementation of national HPV vaccination initiatives: a systematic review
Adolescents Adults Human papillomavirus (HPV) Efficacy/effectiveness Coverage
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Gloeck, N. R. Leong, T. D. Mthethwa, M. Iwu-Jaja, C. J. Katoto, Pdmc Wiysonge, C. S. Kredo, T.
Typhoid conjugate vaccines for preventing typhoid fever (enteric fever)
Children Adolescents Adults Older adults Typhoid Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
High
2025 ∙ Bardach, A. Brizuela, M. Berrueta, M. Ciapponi, A. Sambade, J. M. Ballivian, J. Ortega, V. Castellana, N. Comande, D. Parker, E. P. K. Kampmann, B. Stegelmann, K. Xiong, X. Stergachis, A. Munoz, F. M. Buekens, P. Mazzoni, A.
Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines
Pregnant women Newborn Children Adolescents Chikungunya Safety
Methodological quality (AMSTAR 2):
Not applicable
Loading...